iTeos Therapeutics's market cap is currently $273.27M. The company's EPS TTM is $-3.149; its P/E ratio is ―; iTeos Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-1.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 12.60M	$ 267.63M	$ 344.77M	$ 0.00	$ 0.00
Gross Profit	$ 11.70M	$ 266.82M	$ 344.16M	$ -535.00K	$ -611.00K
Operating Income	$ -151.10M	$ 126.32M	$ 244.90M	$ -45.24M	$ -28.05M
EBITDA	$ -151.10M	$ 148.38M	$ 257.08M	$ -37.84M	$ -21.72M
Net Income	$ -112.64M	$ 96.65M	$ 214.52M	$ -38.03M	$ -22.45M
Balance Sheet
Cash & Short-Term Investments	$ 531.92M	$ 613.16M	$ 848.54M	$ 336.33M	$ 19.87M
Total Assets	$ 667.59M	$ 754.99M	$ 884.71M	$ 344.56M	$ 30.74M
Total Debt	$ 6.06M	$ 4.67M	$ 5.34M	$ 0.00	$ 5.40M
Net Debt	$ -245.12M	$ -280.13M	$ -843.20M	$ -336.33M	$ -14.47M
Total Liabilities	$ 92.36M	$ 91.66M	$ 331.89M	$ 21.36M	$ 15.07M
Stockholders' Equity	$ 575.23M	$ 663.33M	$ 552.82M	$ 323.20M	$ 15.67M
Cash Flow
Free Cash Flow	$ -106.72M	$ -112.13M	$ 511.96M	$ -25.53M	$ -23.87M
Operating Cash Flow	$ -103.76M	$ -111.19M	$ 513.14M	$ -25.18M	$ -23.14M
Investing Cash Flow	$ 72.66M	$ -446.06M	$ -1.24M	$ -377.00K	$ -926.00K
Financing Cash Flow	$ 1.11M	$ 1.98M	$ 3.66M	$ 340.34M	$ 22.54M

Currency in USD

iTeos Therapeutics Earnings and Revenue History

Income Statement >

iTeos Therapeutics Debt to Assets

Balance Sheet >

iTeos Therapeutics Cash Flow

Cash Flow >

iTeos Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing